Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma
Clinical trial NCT04417166 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04417166
- Sponsor
- International Extranodal Lymphoma Study Group (IELSG)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-11
- Primary completion
- 2026-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.